Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 300 /hr
Hire Dr. Mehdi J.
United Kingdom
USD 300 /hr
I hold a Ph.D. in Health Economics and have about 20 years of experience in academia and industry.
Profile Summary
Subject Matter Expertise
Services
Writing
Clinical Trial Documentation,
Technical Writing,
Copywriting
Research
Market Research,
User Research,
Meta-Research,
Fact Checking,
Gap Analysis,
Gray Literature Search,
Systematic Literature Review,
Secondary Data Collection
Consulting
Digital Strategy Consulting,
Scientific and Technical Consulting
Data & AI
Predictive Modeling,
Statistical Analysis,
Algorithm Design-Non ML,
Data Visualization,
Data Processing,
Data Insights
Product Development
Prototyping
Work Experience
CEO
Optimax Access
August 2017 - Present
Senior Consultant
Parexel
January 2016 - Present
Research fellow
University of Aberdeen
December 2013 - November 2015
Faculty Memeber
SUMS
September 2008 - November 2013
Education
PhD Health Economics
IUMS
February 2010 - November 2013
MSc Health Economics
IUMS
September 2006 - September 2008
Certifications
- Certification details not provided.
Publications
JOURNAL ARTICLE
Javanbakht, M., Azuara-Blanco, A., Burr, J.M., Ramsay, C., Cooper, D., Cochran, C., Norrie, J., Scotland, G.(2017). Early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma: An economic evaluation based on data from the EAGLE trial . BMJ Open. 7. (1).
Vos, T., Allen, C., Arora, M., Barber, R.M., Bhutta, Z.A., Brown, A., Carter, A., Casey, D.C., Charlson, F.J., Chen, A.Z., et al.(2016). Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 . The Lancet. 388. (10053). p. 1545-1602.
Kassebaum, N.J., Barber, R.M., Bhutta, Z.A., Dandona, L., Gething, P.W., Hay, S.I., Kinfu, Y., Larson, H.J., Liang, X., Lim, S.S., et al.(2016). Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 . The Lancet. 388. (10053). p. 1775-1812.
Haghighat, S., Akbari, M.E., Yavari, P., Javanbakht, M., Ghaffari, S.(2016). Cost-effectiveness of three rounds of mammography breast cancer screening in iranian women . Iranian Journal of Cancer Prevention. 9. (1). p. 1-8.
Scotland, G., McKeigue, P., Philip, S., Leese, G.P., Olson, J.A., Looker, H.C., Colhoun, H.M., Javanbakht, M.(2016). Modelling the cost-effectiveness of adopting risk-stratified approaches to extended screening intervals in the national diabetic retinopathy screening programme in Scotland . Diabetic Medicine. 33. (7). p. 886-895.
Yazdani-Bakhsh, R., Javanbakht, M., Sadeghi, M., Mashaiekhi, A., Ghaderi, H., Rabiei, K.(2016). Comparison of health-related quality of life after percutaneous coronary intervention and coronary artery bypass surgery . ARYA Atherosclerosis. 12. (3).
Forouzanfar, M.H., Afshin, A., Alexander, L.T., Anderson, H.R., Bhutta, Z.A., Biryukov, S., Brauer, M., Burnett, R., Cercy, K., Charlson, F.J., et al.(2016). Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 . The Lancet. 388. (10053). p. 1659-1724.
Wang, H., Bhutta, Z.A., Coates, M.M., Coggeshall, M., Dandona, L., Diallo, K., Franca, E.B., Fraser, M., Fullman, N., Gething, P.W., et al.(2016). Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 . The Lancet. 388. (10053). p. 1725-1774.
Lim, S.S., Allen, K., Bhutta, Z.A., Dandona, L., Forouzanfar, M.H., Fullman, N., Gething, P.W., Goldberg, E.M., Hay, S.I., Holmberg, M., et al.(2016). Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015 . The Lancet. 388. (10053). p. 1813-1850.
Keshavarz, K., Kebriaeezadeh, A., Alavian, S.M., Sari, A.A., Hemami, M.R., Lotfi, F., Meshkini, A.H., Javanbakht, M., Keshvari, M., Nikfar, S.(2016). A cost-utility and cost-effectiveness analysis of different oral antiviral medications in patients with HBeAg-negative chronic hepatitis B in Iran: An economic microsimulation decision model . Hepatitis Monthly. 16. (9).
Azuara-Blanco, A., Burr, J., Ramsay, C., Cooper, D., Foster, P.J., Friedman, D.S., Scotland, G., Javanbakht, M., Cochrane, C., Norrie, J.(2016). Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial . The Lancet. 388. (10052). p. 1389-1397.
Khalil, I., Colombara, D.V., Forouzanfar, M.H., Troeger, C., Daoud, F., Moradi-Lakeh, M., El Bcheraoui, C., Rao, P.C., Afshin, A., Charara, R., et al.(2016). Burden of diarrhea in the eastern mediterranean region, 1990-2013: Findings from the global burden of disease study 2013 . American Journal of Tropical Medicine and Hygiene. 95. (6). p. 1319-1329.
Wang, H., Naghavi, M., Allen, C., Barber, R.M., Bhutta, Z.A., Carter, A., Casey, D.C., Charlson, F.J., Chen, A.Z., Coates, M.M., et al.(2016). Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 . The Lancet. 388. (10053). p. 1459-1544.
Wang, H., Wolock, T.M., Carter, A., Nguyen, G., Kyu, H.H., Gakidou, E., Hay, S.I., Mills, E.J., Trickey, A., Msemburi, W., et al.(2016). Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015 . The Lancet HIV. 3. (8). p. e361-e387.
Javanbakht, M., Mashayekhi, A., Baradaran, H.R., Haghdoost, A.A., Afshin, A.(2015). Projection of diabetes population size and associated economic burden through 2030 in Iran: Evidence from micro-simulation Markov model and Bayesian meta-analysis . PLoS ONE. 10. (7).
Javanbakht, M., Keshtkaran, A., Shabaninejad, H., Karami, H., Zakerinia, M., Delavari, S.(2015). Comparison of blood transfusion plus chelation therapy and bone marrow transplantation in patients with β-thalassemia: Application of SF-36, EQ-5D, and visual analogue scale measures . International Journal of Health Policy and Management. 4. (11). p. 733-740.
Javanbakht, M., Moradi-Lakeh, M., Yaghoubi, M., Esteghamati, A., Ghanaie, R.M., Mahmoudi, S., Shamshiri, A.-R., Zahraei, S.M., Baxter, L., Shakerian, S., et al.(2015). Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran . Vaccine. 33. (S1). p. A192-A200.
Javanbakht, M., Bakhsh, R.Y., Mashayekhi, A., Ghaderi, H., Sadeghi, M.(2014). Coronary bypass surgery versus percutaneous coronary intervention: Cost-effectiveness in Iran: A study in patients with multivessel coronary artery disease . International Journal of Technology Assessment in Health Care. 30. (4). p. 366-373.
Javanbakht, M., Mirahmadizadeh, A., Mashayekhi, A.(2014). The long-term effectiveness of methadone maintenance treatment in prevention of hepatitis c virus among illicit drug users: A modeling study . Iranian Red Crescent Medical Journal. 16. (2).
Keshtkaran, A., Mirahmadizadeh, A., Heidari, A., Javanbakht, M.(2014). Cost-effectiveness of Methadone Maintenance Treatment in prevention of HIV among drug users in Shiraz, south of Iran . Iranian Red Crescent Medical Journal. 16. (1).
Hatam, N., Shirvani, S., Javanbakht, M., Askarian, M., Rastegar, M.(2013). Cost-utility analysis of neonatal screening program, Shiraz university of medical sciences, Shiraz, Iran, 2010 . Iranian Journal of Pediatrics. 23. (5). p. 493-500.
Alavian, S.-M., Mirahmadizadeh, A., Javanbakht, M., Keshtkaran, A., Heidari, A., Mashayekhi, A., Salimi, S., Hadian, M.(2013). Effectiveness of methadone maintenance treatment in prevention of hepatitis C virus transmission among injecting drug users . Hepatitis Monthly. 13. (8).
Keshtkaran, A., Javanbakht, M., Salavati, S., Mashayekhi, A., Karimi, M., Nuri, B.(2013). Cost-utility analysis of oral deferasirox versus infusional deferoxamine in transfusion-dependent β-thalassemia patients . Transfusion. 53. (8). p. 1722-1729.
Hatam, N., Pourmohammadi, K., Keshtkaran, A., Javanbakht, M., Askarian, M.(2012). Factors affecting efficiency of social security hospitals in Iran: Data envelopment analysis . HealthMED. 6. (6). p. 1961-1968.
Javanbakht, M., Abolhasani, F., Mashayekhi, A., Baradaran, H.R., Jahangiri noudeh, Y.(2012). Health Related Quality of Life in Patients with Type 2 Diabetes Mellitus in Iran: A National Survey . PLoS ONE. 7. (8).
Javanbakht, M., Baradaran, H.R., Mashayekhi, A., Haghdoost, A.A., Khamseh, M.E., Kharazmi, E., Sadeghi, A.(2011). Cost-of-illness analysis of type 2 diabetes mellitus in Iran . PLoS ONE. 6. (10).